XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in- Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   4,965,901    
Beginning balance at Dec. 31, 2022 $ 14,922 $ 0 $ 187,571 $ (172,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Equity-based compensation 308   308  
Reclassification of common stock warrants to liability (800)   (800)  
Vesting of restricted stock units and related repurchases (in shares)   5,561    
Vesting of restricted stock units and related repurchases (1) $ 1 (2)  
Issuance of common stock, net (in shares)   3,400,000    
Issuance of common stock, net 4,597   4,597  
Net loss (4,407)     (4,407)
Ending balance (in shares) at Mar. 31, 2023   8,371,462    
Ending balance at Mar. 31, 2023 14,619 $ 1 191,674 (177,056)
Beginning balance (in shares) at Dec. 31, 2022   4,965,901    
Beginning balance at Dec. 31, 2022 14,922 $ 0 187,571 (172,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (10,171)      
Ending balance (in shares) at Jun. 30, 2023   8,648,307    
Ending balance at Jun. 30, 2023 9,705 $ 1 192,524 (182,820)
Beginning balance (in shares) at Mar. 31, 2023   8,371,462    
Beginning balance at Mar. 31, 2023 14,619 $ 1 191,674 (177,056)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Equity-based compensation 969   969  
Vesting of restricted stock units and related repurchases (in shares)   276,845    
Vesting of restricted stock units and related repurchases (119)   (119)  
Net loss (5,764)     (5,764)
Ending balance (in shares) at Jun. 30, 2023   8,648,307    
Ending balance at Jun. 30, 2023 $ 9,705 $ 1 192,524 (182,820)
Beginning balance (in shares) at Dec. 31, 2023 8,650,753 8,650,753    
Beginning balance at Dec. 31, 2023 $ 3,031 $ 1 192,593 (189,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Equity-based compensation 5   5  
Vesting of restricted stock units and related repurchases (in shares)   197    
Net loss (829)     (829)
Ending balance (in shares) at Mar. 31, 2024   8,650,950    
Ending balance at Mar. 31, 2024 $ 2,207 $ 1 192,598 (190,392)
Beginning balance (in shares) at Dec. 31, 2023 8,650,753 8,650,753    
Beginning balance at Dec. 31, 2023 $ 3,031 $ 1 192,593 (189,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (1,429)      
Ending balance (in shares) at Jun. 30, 2024 8,651,148 8,651,148    
Ending balance at Jun. 30, 2024 $ 1,613 $ 1 192,604 (190,992)
Beginning balance (in shares) at Mar. 31, 2024   8,650,950    
Beginning balance at Mar. 31, 2024 2,207 $ 1 192,598 (190,392)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Equity-based compensation 6   6  
Vesting of restricted stock units and related repurchases (in shares)   198    
Net loss $ (600)     (600)
Ending balance (in shares) at Jun. 30, 2024 8,651,148 8,651,148    
Ending balance at Jun. 30, 2024 $ 1,613 $ 1 $ 192,604 $ (190,992)